Bruker Corporation (BRKR)

SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Dr. Frank H. Laukien, Ph.D. , CEO/Chairman of the Board/President/Director
Industry: Technology
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Dr. Frank H. Laukien, Ph.D., CEO/Chairman of the Board/President/Director

40 Manning Park

Billerica, MA 01821

US Map it

Phone: (978) 663-3660

Fax: (978) 667-0985

www.bruker-biosciences.com



Overview

The Company designs, manufactures, services and markets proprietary life science and materials research systems based on mass spectrometry core technology.

Employees

Number of Employees: 2,212
Revenue per Employee: $262,183

Top Executives

William J. Knight, C.P.A., CFO/Treasurer
Brian P. Monahan, C.P.A., Controller/Executive VP, Subsidiary
Dr. Dirk D. Laukien, Ph.D., Director/Senior VP

Board of Directors

William J. Knight, C.P.A., CFO/Treasurer
Dr. Dirk D. Laukien, Ph.D., Director/Senior VP
William A. Linton, Director

Richard D. Kniss, Director
Richard M. Stein, J.D., Director/Secretary
Dr. Stephen W. Fesik, Ph.D., Director Nominee

Richard A. Packer, Director

Financials

Quarterly
Annual

Income Statement 08/2008 05/2008 02/2008 10/2007
Sales 182.83 Mil. 125.31 Mil. 98.1 Mil. 69.81 Mil.
Gross Operating Profit 128.64 Mil. 113.13 Mil. 85.65 Mil. 61.83 Mil.
Operating Income before D & A (EBITDA) 28.8 Mil. 21.73 Mil. 28.02 Mil. 11.46 Mil.
Total Income Before Interest Expenses (EBIT) 31.96 Mil. 3.74 Mil. 23.72 Mil. 11.22 Mil.
Total Net Income 21.69 Mil. -685 K. 14.02 Mil. 8.66 Mil.
Basic EPS, Total 0.13 0 0.13 0.08
Diluted EPS, Total 0.13 0 0.13 0.08

BALANCE STATEMENT 08/2008 05/2008 02/2008 10/2007
Cash and Equivalents 131.79 Mil. 321.28 Mil. 72.88 Mil. 38.9 Mil.
Total Assets 859.23 Mil. 1.09 Bil. 395.63 Mil. 343.44 Mil.
Total Liabilities 573.75 Mil. 831.61 Mil. 252.95 Mil. 210.45 Mil.
Total Capitalization 487.22 Mil. 459.14 Mil. 265.05 Mil. 256.59 Mil.

Cash Flow 08/2008 05/2008 02/2008 10/2007
Net Cash From Continuing Operations NA NA NA -10.15 Mil.
Net Cash From Investing Activities NA NA NA -16.49 Mil.
Net Cash From Financing Activities NA NA NA 10.89 Mil.
Net Change in Cash & Cash Equivalents NA NA NA -13.24 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales 294.44 Mil. 223.21 Mil. 163.15 Mil. 156.15 Mil.
Gross Operating Profit 253.14 Mil. 212.62 Mil. 134.42 Mil. 128.27 Mil.
Operating Income before D & A (EBITDA) 54.63 Mil. 49.68 Mil. 19.25 Mil. 8.68 Mil.
Total Income Before Interest Expenses (EBIT) 49.97 Mil. 36.58 Mil. 11.95 Mil. -1.12 Mil.
Total Net Income 31.53 Mil. 18.48 Mil. 3.65 Mil. -7.83 Mil.
Basic EPS, Total 0.3 0.18 0.04 -0.06
Diluted EPS, Total 0.3 0.18 0.04 -0.06

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 72.88 Mil. 52.15 Mil. 53.16 Mil. 32.55 Mil.
Total Assets 395.63 Mil. 294.74 Mil. 265.61 Mil. 271.29 Mil.
Total Liabilities 252.95 Mil. 195.13 Mil. 111.53 Mil. 111.16 Mil.
Total Capitalization 265.05 Mil. 214.33 Mil. 229.22 Mil. 245.04 Mil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations NA 37.69 Mil. 42.19 Mil. -889 K.
Net Cash From Investing Activities NA 12.3 Mil. -10.45 Mil. -1.51 Mil.
Net Cash From Financing Activities NA -64.38 Mil. -7.18 Mil. 6.77 Mil.
Net Change in Cash & Cash Equivalents NA -10.48 Mil. 20.61 Mil. 7.2 Mil.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
1.1 Bil.
1.21 Bil.
1.29 Bil.
1.01 Bil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented